Member Info for FSA15

'Gap-analysis' ha-ha hilarious!

Thanks for another random rumour :-)
#rampramp

a) this deal could be completed and land tomorrow. BUT it can also take months to be completed and land near Xmas!
b) what is the price of the sale? Is it the £3m being touted on this ramp board? What if its something like £1m ...that news would send the sp here crashing!?

It's a big red flag when you see folks wanting to only see positive discussion on the board. Any genuine discussion that is not 100% positive is seen as deramping!

Transactions like the one expected can take months and months I guess. All the t&c's etc

When can you expect news to come through? I.e. within a week/month?

Is this price drop a good entry point or an indicator that the sale is/has not gone as well as wished

Thanks ihavenoclue

I dont and I'm sure many others neither so enlighten us all please

Yeah agreed in that i'm not convinced this is the bottom yet.
My question is though, why is the sp near year low's and not much higher when there is so much big news to come!?
And financing is apparently sorted until Q2 2020

Diurnal - anyone have any experience on this one?
So much big news on the horizon i.e. this coming Q4 - yet the sp quite low

Haha c'mon have a bit more optimism when it comes to ICONIC ;-)

RNS imminent!

Are we about to see this shoot back up after the recent drops?
Supposedly lots of news on the horizon this quarter

So big?

They appear to be financed 'until at least Q2 2020'

Financial outlook



Following the cost reduction measures outlined above and the net proceeds from the placing and open offer completed in June 2019, Diurnal expects its cash resources to last until at least Q2 2020 based upon current planned expenditure which is focused on submission of marketing authorisation applications for Chronocort® in Europe and Alkindi® in the US and continued development of the European commercial organisation and roll-out of Alkindi® together with ongoing licensing disussions. Diurnal believes that submission of the marketing authorisation applications, planned for Q4 2019, are key steps in the implementation of the Group's strategic plans that will support further financing activities. In addition, the Group is encouraged by US interest in its late-stage pipeline, which provides an opportunity to generate non-dilutive income, including potential for signature fees, milestone payments and development cost funding.

We are officially into Q4.
From reading into this company yesterday it looks like there is plenty going on with lots to expect this quarter.
But why is the sp near year lows?
They are according to the last rns, financed until mid next year.

Why is this at such low sp when there is so much news/potential before the end of this year?
I assume it's all down to investor confidence after the ema didn't give the full thumbs up?

Party at the office!?
How much further can this fall!?

De ja vu
As much as I'd love that to be the case, unfortunately I've got to add 'han't we heard that before!?'

Indicates legacy issues substantially complete!